News | Molecular Imaging | July 02, 2015

Mevion Medical Systems Delivers Proton Accelerator to Seidman Cancer Center at University Hospitals

Mevion S250 will be Ohio's first proton therapy system when operation begins in spring 2016

Mevion, S250, Seidman Cancer Center, University Hospitals, UH, proton therapy

July 2, 2015 - Mevion Medical Systems announced delivery of the superconducting synchrocyclotron accelerator for its Mevion S250 proton therapy system for installation at University Hospitals (UH) Seidman Cancer Center and UH Rainbow Babies & Children's Hospital in Cleveland.

The accelerator is the core of the proton therapy system, and its installation is a crucial step in the deployment of the system at UH. The unit will be the first proton therapy system in Ohio treating adult and pediatric cancer patients when it begins clinical operation in the spring of 2016. This is the sixth accelerator delivery for Mevion.

"We are extremely excited to bring this leading-edge proton beam facility to Ohio," said Nathan Levitan, M.D., president of UH Seidman Cancer Center. "As a national leader in cancer care, University Hospitals Seidman Cancer Center is committed to providing patients with the most advanced cancer-fighting technology and treatments. The addition of the Mevion S250 will be a great complement to our existing state-of-the-art radiation oncology equipment and expertise and will benefit patients with many different types of cancer. Additionally, it provides a distinct advantage to our pediatric patients and their families at UH Rainbow Babies & Children's Hospital, eliminating the need to travel out of state for this technology, which results in fewer long-term effects due to the precisely targeted therapy."

Proton therapy is an advanced form of radiation therapy that targets cancer cells more directly while sparing much of the surrounding healthy tissue, thus making it ideal for treating pediatric patients as well as adults with cancer in sensitive locations such as near the heart or brain. Traditional proton therapy systems cost hundreds of millions of dollars to build and are typically the size of a football field. However, the Mevion S250 provides precise, effective and efficient treatment without the complexity of traditional systems. In addition, the capital costs and the operating costs are significantly less as the Mevion S250 requires less space, less staff and less energy than other proton systems.

Following the installation of the accelerator, the system will undergo proton beam tuning and acceptance testing to verify that it meets precise technical and clinical requirements before being commissioned for clinical use. It is expected to begin treating cancer patients in the spring of 2016. 

Currently, three Mevion S250 proton therapy systems are in clinical operation treating patients.

For more information: www.mevion.com

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Overlay Init